Metachronous Double Primary Cancer after Diagnosis of Gastric Cancer
Open Access
- 1 September 2012
- journal article
- Published by Korean Cancer Association in Cancer Research and Treatment
- Vol. 44 (3), 173-178
- https://doi.org/10.4143/crt.2012.44.3.173
Abstract
The pattern of double primary cancers after treatment for gastric cancer is important for a patient's survival. We analyzed the clinicopathologic data of 214 gastric cancer patients from October 1996 to November 2007 with regard to metachronous second primary cancers. Out of 5,778 patients with gastric cancer, metachronous second primary cancers occurred in 214 patients. The median age was 61.8 years, the number of male and female patients was 140 (65.4%), 74 (34.6%), respectively. The median time to the occurrence of second cancers after diagnosis of the first was 39.2 months (standard deviation, 31.2 months). The most common cancer was colorectal cancer, which occurred in 44 patients (20.6%), and lung cancer in 33 patients (15.4%), hepatocellular carcinoma in 26 patients (12.1%), ovarian cancer in 15 patients (7.0%), cervical cancer in 12 patients (7.0%), breast cancer in 11 patients (5.1%), and esophageal cancer in 11 patients (5.1%). The observed/expected (O/E) ratio showed a significant increase in colorectal (1.25), male biliary (1.60), ovarian (8.72), and cervical cancer (3.33) with primary gastric cancer. After five years from diagnosis of gastric cancer, secondary cancer occurred in 50 patients (23.4%), and breast cancer, prostate cancer, laryngeal cancer, lung cancer, and hepatocellular carcinoma were the most frequent. The O/E ratio showed a significant increase in colorectal, male biliary, ovarian, and cervical cancer with primary gastric cancer, and second primary cancer as the main cause of death for these patients. A follow-up examination for metachronous double primary cancer is needed in order to improve the survival time in patients with gastric cancer.Keywords
This publication has 18 references indexed in Scilit:
- Dual Primary Gastric and Colorectal CancerAmerican Journal of Clinical Oncology, 2012
- Double primary malignancy in colorectal cancer patients—MSI is the useful marker for predicting double primary tumorsInternational Journal of Colorectal Disease, 2008
- Synchronous and metachronous cancers in patients with gastric cancerJournal of Surgical Oncology, 2008
- Gastric cancer patients at high-risk of having synchronous cancerWorld Journal of Gastroenterology, 2006
- Multiple primary cancers of separate organ sites: implications for research and cancer control (Australia)Cancer Causes & Control, 2005
- Evaluation of Risk Factors for Nasopharyngeal Carcinoma in High-Risk Nasopharyngeal Carcinoma Families in TaiwanCancer Epidemiology, Biomarkers & Prevention, 2005
- Estimates of Cancer Incidence in China for 2000 and Projections for 2005Cancer Epidemiology, Biomarkers & Prevention, 2005
- SHORT COMMUNICATION: Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancersCarcinogenesis: Integrative Cancer Research, 1996
- Second Primary Cancer after Diagnosis of Stomach Cancer in Osaka, JapanJapanese Journal of Cancer Research, 1991
- The Risk of Gastrointestinal and other Primary Malignant Diseases Following Gastric CancerActa Oncologica, 1991